We propose to develop, implement and evaluate a new education and career development program at the H. Lee Moffitt Cancer Center and Research Institute in Tampa, Florida. The program will provide a specialized curriculum to prepare future academic researchers to integrate the latest technologies and full spectrum of outcomes (from risk to survival) in observational molecular and genetic epidemiology. Two postdoctoral fellows per year with advanced degrees in epidemiology, biostatistics, medicine or a related discipline will be recruited for a 2-3 year training program within this specialty area in cancer prevention and control that continues to see a shortage of qualified investigators. Fellows will participate in a multidisciplinary training experience that includes a core curriculum in molecular epidemiology, clinical oncology, cancer biology, plus special workshops in applied methodologies. Seminars developed for this training will include a survey of applications involving high-throughput advanced technologies and methods such as proteomics, genome-wide association studies, nanotechnology, gene expression profiling, and mathematical oncology that are leading the way to advances in screening, risk assessment, biomonitoring, and individual-based diagnosis and treatment, i.e. personalized medicine. In addition to the specialized curriculum in molecular epidemiology, a tailored program will be developed for each trainee that combines formal course work and hands-on experience in molecular, basic and clinical research under the guidance of at least two established investigators from different disciplines. In addition to a wide array of large, well-designed molecular and genetic epidemiologic studies, a unique asset for training at Moffitt is the availability of lifestyle, clinical and outcome data and biospecimens collected on many thousands of screening and cancer patients as part of Moffitt's Total Cancer Care research program. These resources afford an opportunity for trainees to apply study design and technology advances in personalized cancer care research. Each fellow will be required to define a research topic in the area of molecular or genetic epidemiology and write and defend a real or mock research grant or career development award application. Ongoing monitoring and over sight of the program by a dedicated faculty, and internal and external advisory boards, will ensure success in recruiting qualified candidates from multiple disciplines and backgrounds, and a training experience that prepares cancer researchers for careers in a rapidly changing, highly technical, interdisciplinary research environment.

Public Health Relevance

Molecular and genetic epidemiology are at the forefront of advances in cancer risk assessment and personalized medicine. Currently, there is a shortage of scientists with specialized training in these areas. The proposed new postdoctoral fellowship program will provide interdisciplinary training and research experience needed for success in these rapidly advancing fields.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Education Projects (R25)
Project #
5R25CA147832-05
Application #
8677770
Study Section
Subcommittee G - Education (NCI)
Program Officer
Perkins, Susan N
Project Start
2010-06-01
Project End
2015-05-31
Budget Start
2014-06-01
Budget End
2015-05-31
Support Year
5
Fiscal Year
2014
Total Cost
$400,492
Indirect Cost
$29,960
Name
H. Lee Moffitt Cancer Center & Research Institute
Department
Type
DUNS #
139301956
City
Tampa
State
FL
Country
United States
Zip Code
33612
Egan, Kathleen M; Baskin, Rebekah; Nabors, L Burton et al. (2015) Brain tumor risk according to germ-line variation in the MLLT10 locus. Eur J Hum Genet 23:132-4
Giuliano, Anna R; Botha, Matthys H; Zeier, Michele et al. (2015) High HIV, HPV, and STI prevalence among young Western Cape, South African women: EVRI HIV prevention preparedness trial. J Acquir Immune Defic Syndr 68:227-35
Cragun, Deborah; Camperlengo, Lucia; Robinson, Emily et al. (2015) Differences in BRCA counseling and testing practices based on ordering provider type. Genet Med 17:51-7
Giuliano, Anna R; Nyitray, Alan G; Kreimer, Aimée R et al. (2015) EUROGIN 2014 roadmap: differences in human papillomavirus infection natural history, transmission and human papillomavirus-related cancer incidence by gender and anatomic site of infection. Int J Cancer 136:2752-60
Taylor, Nicholas J; Reiner, Anne S; Begg, Colin B et al. (2015) Inherited variation at MC1R and ASIP and association with melanoma-specific survival. Int J Cancer 136:2659-67
Cragun, Deborah; DeBate, Rita D; Pal, Tuya (2015) Applying public health screening criteria: how does universal newborn screening compare to universal tumor screening for Lynch syndrome in adults with colorectal cancer? J Genet Couns 24:409-20
Stanley, Margaret A; Sudenga, Staci L; Giuliano, Anna R (2014) Alternative dosage schedules with HPV virus-like particle vaccines. Expert Rev Vaccines 13:1027-38
Sudenga, Staci L; Shrestha, Sadeep; Macaluso, Maurizio et al. (2014) Functional variants in CYP1A1 and GSTM1 are associated with clearance of cervical HPV infection. Gynecol Oncol 135:560-4
Madden, Melissa H; Anic, Gabriella M; Thompson, Reid C et al. (2014) Circadian pathway genes in relation to glioma risk and outcome. Cancer Causes Control 25:25-32
Nyitray, Alan G; Lin, Hui-Yi; Fulp, William J et al. (2014) The role of monogamy and duration of heterosexual relationships in human papillomavirus transmission. J Infect Dis 209:1007-15

Showing the most recent 10 out of 29 publications